Starting lipid-lowering treatment earlier in life may reduce cardiovascular risk in patients with familial hypercholesterolemia vs those who do not, a meta-analysis suggests. Medscape Medical News
Starting lipid-lowering treatment earlier in life may reduce cardiovascular risk in patients with familial hypercholesterolemia vs those who do not, a meta-analysis suggests. Medscape Medical News